0001437749-20-021722.txt : 20201027
0001437749-20-021722.hdr.sgml : 20201027
20201027205125
ACCESSION NUMBER: 0001437749-20-021722
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201023
FILED AS OF DATE: 20201027
DATE AS OF CHANGE: 20201027
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LeMaitre George W
CENTRAL INDEX KEY: 0001365737
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 201265864
MAIL ADDRESS:
STREET 1: 342 BUNKER HILL STREET, #2B
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rdgdoc.xml
FORM 4
X0306
4
2020-10-23
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365737
LeMaitre George W
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
1
1
Chairman and CEO
Common Stock
2020-10-23
4
M
0
31732
14.13
A
2994386
D
Common Stock
2020-10-23
4
M
0
12747
23.56
A
3007133
D
Common stock
20000
I
See footnote
Stock Option (Right to Buy)
14.13
2020-10-23
4
M
0
31732
0
D
2016-07-25
2021-07-25
Common Stock
31732
31733
D
Stock Option (Right to Buy)
23.56
2020-10-23
4
M
0
12747
0
D
2018-12-19
2023-12-19
Common Stock
12747
50987
D
Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
These shares are owned by LeMaitre Family LLC. A trust for the benefit of the Reporting Person holds a 20% membership interest in LeMaitre Family LLC. LeMaitre Family LLC is 100% owned by Christopher Lynch, as trustee for various trusts formed for the benefit of the children of George D. LeMaitre, the Issuer's founder, and Cornelia W. LeMaitre. LeMaitre Family LLC currently holds 100,000 shares of the Issuer's Common Stock. The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary.
The expiration date of this option to the extent it is an incentive stock option is 12/19/2023, and the expiration date of this option to the extent it is a nonqualified stock option is 12/19/2025.
/s/ Laurie A. Churchill, Attorney-in-fact
2020-10-27